Avalon Produits Sanitaires Et De Sante Inc. – Trademark Portfolio

Entity Type: 03

Avalon Produits Sanitaires Et De Sante Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. The owner is based in Montreal, Quebec.

Suite 2000

1245 Sherbrooke Street West

Montreal, Quebec H3G 1G2 , CA

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Avalon Produits Sanitaires Et De Sante Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

3
Cosmetics & Cleaning (3 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Avalon Produits Sanitaires Et De Sante Inc. have?

Avalon Produits Sanitaires Et De Sante Inc. has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Avalon Produits Sanitaires Et De Sante Inc. file in?

Avalon Produits Sanitaires Et De Sante Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is Avalon Produits Sanitaires Et De Sante Inc.'s trademark registration success rate?

Avalon Produits Sanitaires Et De Sante Inc. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.